Kairos Discovery
Develops next-generation targeted cancer therapies for patients with cancer
Highlights
- Young companyFounded 2022
- New on EvolcAdded 2026-11-10
About Kairos Discovery
Kairos Discovery is developing targeted cancer therapies based on kinase-targeting approaches, including a bivalent CK2α inhibitor and a CDK-targeted protein degrader. Its programs aim to address limitations of conventional kinase inhibitors.
The company was founded in 2022 and is based in Lyon, France. Its team includes scientists and drug-development specialists working on preclinical research and chemistry operations.
Product: A drug-discovery pipeline focused on a bivalent CK2α inhibitor and a CDK-targeted protein degrader for oncology.
Jobs at Kairos Discovery
Leadership
- Alexandre Arnaud · Co-founder, Chemistry & Quality OperationsSource: company website
- Alexandre Bancet · CEO, Board memberSource: company website
- David Neves · Co-founder, Head of Preclinical R&DSource: company website
More biotech & pharma companies
Kalsiom
Biotech developing monoclonal antibodies that modulate calcium signaling in B cells for autoimmune diseasesNew on EvolcKcas Bio
Bioanalytical and biomarker testing services for pharmaceutical and biotechnology drug developersKekkan Biologics
Develops antibody biologics for cancer and fibrotic disorders, initially targeting triple-negative breast cancerYoung companyNew on EvolcKeybio
Microbiological testing and regulatory support for industrial product developers and manufacturersKimialys
Biosensing surface chemistry and lateral flow assay development for diagnostics and drug discovery labsNew on EvolcKinnov Therapeutics
Developer of KT-110, an oral drug candidate for alcohol use disorder, in clinical development for addiction treatmentNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Response headerserver
- Response headerserver
Content management
- WebflowHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.